BSX
Boston Scientific Corp
NYSE: BSX · HEALTHCARE · MEDICAL DEVICES
$57.61
+0.80% today
Updated 2026-04-29
Market cap
$92.25B
P/E ratio
25.97
P/S ratio
4.48x
EPS (TTM)
$2.39
Dividend yield
—
52W range
$59 – $110
Volume
15.7M
Boston Scientific Corp (BSX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+3.0%
Last 4 quarters
Revenue YoY growth
+11.6%
Most recent quarter
EPS YoY growth
+6.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.8%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-15.3%
2026-02-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-22 | $0.80 | +1.0% | $59.52 | $65.69 | +10.4% |
| 2026-02-04 | $0.80 | +2.6% | $91.62 | $77.64 | -15.3% |
| 2025-10-22 | $0.75 | +5.6% | $99.90 | $102.39 | +2.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $0.79 | $0.80 | +1.0% | $5.20B | +11.6% |
| 2025-12-31 | $0.78 | $0.80 | +2.6% | $5.29B | +15.9% |
| 2025-09-30 | $0.71 | $0.75 | +5.6% | $5.07B | +20.3% |
| 2025-06-30 | $0.73 | $0.75 | +2.7% | $5.06B | +22.8% |
| 2025-03-31 | $0.67 | $0.75 | +11.9% | $4.66B | +20.9% |
| 2024-12-31 | $0.66 | $0.70 | +6.1% | $4.56B | +22.4% |
| 2024-09-30 | $0.59 | $0.63 | +6.8% | $4.21B | +19.3% |
| 2024-06-30 | $0.58 | $0.62 | +6.9% | $4.12B | — |
| 2024-03-31 | $0.51 | $0.56 | +9.8% | $3.86B | — |
| 2023-12-31 | $0.51 | $0.55 | +7.8% | $3.73B | — |
| 2023-09-30 | $0.48 | $0.50 | +4.2% | $3.53B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $3.50 | $22.5B | +12.0% | 21 | high |
| 2027 (E) | $3.96 | $24.8B | +10.4% | 21 | high |
| 2028 (E) | $4.48 | $27.3B | +9.9% | 21 | medium |
| 2029 (E) | $4.92 | $29.8B | +8.9% | 21 | medium |
| 2030 (E) | $5.35 | $32.2B | +8.3% | 21 | low |
Frequently asked questions
Has Boston Scientific Corp beaten earnings estimates?
Boston Scientific Corp has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +3.0% over the last 4 quarters.
How does BSX stock react to earnings?
BSX stock has moved an average of -0.8% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Boston Scientific Corp's revenue growth rate?
Boston Scientific Corp reported year-over-year revenue growth of +11.6% in its most recent quarter, with EPS growing +6.7% year-over-year.
What is the expected EPS for BSX in 2026?
Analysts expect Boston Scientific Corp to report EPS of $3.50 for fiscal year 2026, on revenue of $22.5B, based on estimates from 21 analysts.